Survey Results: Adoption of AI within US Healthcare Organizations

AIMED and Jvion teamed up to survey the provider and payer markets on how the pandemic has impacted their strategies related to the use and deployment of artificial intelligence. Understand the extent to which AI is being adopted within US healthcare organizations, the decision-making process involved, and the areas in which companies hope to see the greatest impact — and how the payer and provider markets differ in their approaches.

Key Findings:
  • In terms of adoption, there is still a third of the market that is not yet engaging with AI.
  • Just under half are actually working on AI projects, with 20% already in deployment.
  • Clinical performance is seen as the area where AI can help the most, with patient experience also in the top four.
  • However, buying decisions tend to be led by the desire for immediate ROI, and typically this can more easily be achieved in back office functions such as RCM and staffing.
  • There is little consistency around tech/innovation buying decisions.
  • Although these decisions are typically led by the C-Suite and/or senior-level committee.
  • COVID-19 has not had a demonstrable impact on the adoption of AI.
Complete the form to download the full report.

Get in Touch

  • 470-427-2900, 3965 Johns Creek Court, Suite 100, Suwanee, GA 30024
  • This field is for validation purposes and should be left unchanged.